Clinical Trials Logo

Clinical Trial Summary

Maple Syrup Urine Disease (MSUD) is a disorder of protein metabolism that leads to neurological differences. It is an exciting time where people diagnosed with MSUD are living longer. The investigators want to learn about how adults with MSUD think, feel, and live. The purpose of this research study is to 1) look at thinking skills, behavior skills, life skills, and quality of life in adults with MSUD and 2) measure how medical and personal factors impact these areas. The results of the study will be used to learn how to best help adults with MSUD and how to prepare for their success. In this study, the participants will answer questions on thinking, life skills, behavior skills, and quality of life. These questions will be completed on the internet. The participants will have a formal testing of their thinking and behavior completed virtually. The participants may also have a 1-2-hour telephone conversation about their life. All tests will occur virtually at home. The investigators will send the participants a letter with the results of thinking and behavior tests.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04828863
Study type Observational
Source Children's Hospital of Philadelphia
Contact
Status Completed
Phase
Start date June 12, 2021
Completion date November 30, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT05687474 - Baby Detect : Genomic Newborn Screening
Recruiting NCT05910151 - Selective Screening of Children for Hereditary Metabolic Diseases by Tandem Mass Spectrometry in Kazakhstan
Recruiting NCT05051657 - Evaluation of the Express Plus Range N/A
Recruiting NCT04602325 - Systemic Biomarkers of Brain Injury From Hyperammonemia
Completed NCT01529060 - Phenylbutyrate Therapy for Maple Syrup Urine Disease Phase 2/Phase 3
Completed NCT04248062 - Patient and Observer Reported Outcome Measurements in Inborn Errors of Metabolism